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Prognostic factors for successful
outcome in patients undergoing
controlled ovarian stimulation and
intrauterine insemination
Objective. To determine the prognostic factors associated with successful outcome
following controlled ovarian stimulation and intrauterine insemination.
Design. Retrospective analysis.
Setting. University-based assisted reproductive technology centre, Hong Kong.
Patients and methods. Patients included 292 couples undergoing 600 treatment
cycles, following a standard protocol of human menopausal gonadotrophin
injections. Multiple logistic regression analysis was performed to determine which
demographic and sperm parameters gave the maximum discrimination to predict
pregnancy.
Results. One hundred and eleven pregnancies resulted from treatment. The
pregnancy rates were 18.5% per cycle and 37.9% per couple. The age of the
women was significantly lower for pregnant cycles, and the serum oestradiol
levels and number of follicles greater than 16 mm in diameter were significantly
higher, compared with non-pregnant cycles. The sperm concentration and number
of motile spermatozoa were also significantly increased in pregnant cycles.
Pregnancy rate was significantly increased when the raw semen sample contained
20 million/mL or more spermatozoa, normal forms comprised 7% or more, and
when the number of motile spermatozoa in inseminated samples was 1 million
or greater.
Conclusion. Using multiple logistic regression analysis, age of the women and
serum oestradiol level had the maximum power to predict pregnancy following
ovarian stimulation and intrauterine insemination.
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Introduction
Intrauterine insemination (IUI) in conjunction with controlled ovarian stimulation
(COS) is usually offered to infertile couples if the woman has patent fallopian
tubes, prior to other assisted reproductive methods. Controlled ovarian stimulation
may correct subtle problems of ovulation, increase the number of oocytes available
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for fertilisation, and enhance the accuracy of timing of
insemination. The rationale for performing IUI is that a
higher number of motile spermatozoa with normal forms
can be inseminated around the time of ovulation to the
uterine cavity, closer to the site of fertilisation. Moreover,
sperm preparation removes leukocytes and dead and
moribund spermatozoa from the semen sample. These can
generate free oxygen radicals and reduce the functional
capacity of intact spermatozoa.1,2
The aim of this retrospective analysis was to determine
prognostic factors for successful outcome following COS/IUI.
Patients and methods
Six hundred COS/IUI cycles for 292 couples completed
between February 1993 and August 2001 at the Department
of Obstetrics and Gynaecology, Queen Mary Hospital, were
analysed retrospectively. All women in this study had a
diagnosis of infertility for more than 2 years, regular
menstrual cycles, bilateral patent fallopian tubes shown on
diagnostic laparoscopy, and no contra-indications for
pregnancy. Patients with multiple causes of infertility or
anovulation were excluded from the study.
All patients underwent COS using human menopausal
gonadotrophin (HMG). On the second day of the treatment
cycle, the serum oestradiol (E2) level was checked and
baseline transvaginal scanning was performed. If E2 level
was less than 220 pmol/L, and there was no ovarian cyst
evident on the scan, treatment of 150 IU of HMG (Pergonal;
Serono, Aubonne, Switzerland) was given intramuscularly
daily from day 3 onwards. The ovarian response was
regularly assessed using both transvaginal scanning and
serum E2 levels. Ten thousand international units of human
chorionic gonadotrophin (HCG) [Profasi; Serono, Aubonne,
Switzerland] were given when the leading follicle was
greater than 18 mm in diameter, and there were no more
than three follicles of greater than 16 mm in diameter.
Patients with an excessive response were counselled to have
the cycle cancelled because of the increased risk of multiple
pregnancy.
The husband was asked to submit a semen sample in a
sterile plastic container about 2 hours before the IUI
procedure, after an abstinence of 2 to 3 days. The sample
was allowed to liquefy completely at room temperature,
usually occurring within 30 minutes. After liquefaction,
sperm preparation was completed by a discontinuous density
gradient centrifugation method, using Percoll (Pharmacia,
Uppsala, Sweden) or Isolate (Irvine Scientific, Santa Ana,
US) sperm separation media.3 The pellet obtained after
centrifugation was washed twice with Earl’s balanced salt
solution (EBSS; Sigma, St Louis, US), supplemented with
0.35% Plasmanate (PPF; Bayer Corporation, Elkhart, US)
or 8% patient’s serum. The resulting sperm pellet after
washing was overlaid with the same medium, adjusting the
final volume to 0.3 mL to 0.5 mL.
Semen analysis was performed according to World
Health Organization (WHO) guidelines,4 both before and
after sperm preparation. Concentration, progressive motility,
and normal morphology were evaluated after staining by
Diff-Quick method.5 A thin and well-spread smear was air-
dried on a clean glass slide at room temperature. The slides
were fixed in Diff-Quick fixative (1.8 mg/L triarylmethane
in methyl-alcohol) for 15 seconds, stained in Diff-Quick
solution 1 (1 g/L xanthene in sodium acide-preserved buffer)
for 10 seconds, and finally in Diff-Quick solution 2 (0.625 g/L
azure A and 0.625 g/L methylene blue in buffer) for
10 seconds. Morphology was assessed by counting 100
spermatozoa using WHO criteria.4
Intrauterine insemination was performed once, 38 hours
after HCG using a Tomcat catheter (Monoject, St Louis,
US) as described previously.6,7 The patient was asked to rest
in the supine position for 15 minutes after the procedure,
and thereafter to resume her routine activities. The luteal
phase was supported by two further doses of 1500 IU HCG
on day 5 and day 10, after the ovulatory HCG injection.
Serum E2 and progesterone levels were also checked on
day 10 after the ovulatory HCG injection. Pregnancy
testing was performed on day 20 after the ovulatory HCG
injection, and if positive, a pelvic ultrasound was arranged
to confirm the presence of an intrauterine pregnancy and
to determine the number of gestational sacs. In vitro
fertilisation treatment was advised if the patient was
not pregnant after three treatment cycles.
Statistical analysis
Only clinical pregnancies were considered in this retro-
spective analysis. A clinical pregnancy was defined as the
presence of an intrauterine gestational sac(s) on scanning,
or products of conception on histological examination in
cases of miscarriage. Biochemical pregnancies were
excluded from the analysis. The number of motile sperm-
atozoa (in millions) was obtained by multiplying semen
volume and the concentration and percentage of progressive
motile spermatozoa. Recovery rate (%) was calculated by
dividing the total motile spermatozoa in the prepared sample
by that of the raw sample.
Data were expressed as median and range. Comparison
of various characteristics in pregnant and non-pregnant
cycles was carried out using the Mann-Whitney U test. Mul-
tiple logistic regression analysis was performed to determine
which demographic and sperm parameters gave maximum
discrimination to predict pregnancy. Statistical analysis
was performed using the Statistical Package for the Social
Sciences (Windows version 10; SPSS Inc., Chicago, US). Two-
tailed P<0.05 values were considered statistically significant.
Results
One hundred and eleven pregnancies were achieved, and
the pregnancy rate (PR) was 18.5% per treatment cycle, and
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37.9% per couple. The PR per cycle was 14.3% (25/175)
for couples with male-factor infertility, and 20.2% (86/425)
for other causes, including mild endometriosis and
unexplained infertility. The multiple PR (twins and triplets)
was 22.6%. There were 12 (10.8%) clinical abortions, and
two (1.8%) ectopic pregnancies. A significantly higher PR
was noted in the first (19.9%) and second (21.1%) cycles
than in the third cycle (12.1%). None of the patients ex-
perienced moderate or severe ovarian hyperstimulation
syndrome.
Table 1 summaries demographic data and ovarian
response data. The median age of women was significantly
lower in pregnant cycles than in non-pregnant cycles (33.0
years vs 34.0 years, P=0.03, Mann-Whitney U test). The
median E2 level and the median number of follicles greater
than 16 mm in diameter on the ovulatory HCG day were
significantly higher in pregnant cycles compared to non-
pregnant cycles.
The volume of semen, percentage of motile spermatozoa
in the raw and inseminated samples, and the recovery rate
of motile spermatozoa were similar in pregnant and non-
pregnant cycles (Table 2). The sperm concentration, the
percentage of normal spermatozoa, and the number of motile
spermatozoa were significantly higher in pregnant than non-
pregnant cycles in both raw and inseminated semen samples.
A significantly higher PR was achieved when the sperm
concentration in the raw semen sample was 20 million/mL
or greater (19.7% vs 9.2%, P<0.05, Chi squared test), or the
percentage of normal morphology was 7% or greater (19.4%
vs 10.3%, P<0.05, Chi squared test). When the number of
motile spermatozoa in inseminated samples was 1 million or
greater, PR was also significantly increased (19.4% vs 3.7%,
P<0.05, Chi squared test). The percentage of progressive
motility in both raw and inseminated samples did not affect
PRs, even when it was as low as 10%.
Using logistic regression analysis, the serum E2 level
on the day of HCG was the most discriminating variable to
predict pregnancy following IUI (P<0.001) [Table 3]. The
age of women showed a negative correlation with pregnancy
(standard discriminant function coefficient β= –0.098,
P=0.009). The log concentration of spermatozoa in the
*selcyctnangerP
)111=n(
*selcyctnangerp-noN
)984=n(
ytilitrefnifosesuaC
rotcafelaM
denialpxenu;sisoirtemodnE
)sraey(nemowfoegA
)sraey(ytilitrefnifonoitaruD
lasuaponemnamuhfoseluopmA
nevignihportodanog
retemaidnimm61>selcilloffo.oN
namuhyrotaluvonolevelloidartseO
)L/lomp(nihportodanogcinoirohc
)mm(elcilloftsegralehtfoeziS
52
68
)0.73-0.52(0.33
)0.31-0.2(0.3
)64-6(41
)5-1(2
)43111-93(0772
)0.52-0.61(7.81
051
933
)0.54-0.32(0.43
)0.31-0.2(0.4
)88-5(41
)5-0(1
)23121-07(8871
)0.82-0.61(0.91
Table 1. Demographic characteristics and ovarian response in pregnant and non-pregnant cycles
* Values reported are the median (range), unless otherwise specified
† P=0.033
‡ P=0.005
§ P<0.001
‡
†
§
‡
†
§
nemeswaR nemesderaperP
tnangerP
*selcyc
tnangerp-noN
*selcyc
eulavP tnangerP
*selcyc
tnangerp-noN
*selcyc
eulavP
)Lm(emuloV
)Lm/noillim(noitartnecnoC
)%(ytilitomevissergorP
elitomfo.oN
)noillim(aozotamreps
ygolohpromlamroN
)%(airetircOHWgnisu
)%(etaryrevoceR
2.3
)0.11-3.0(
0.57
)0.0401-6.1(
0.25
)0.78-0.5(
6.611
)0.4511-2.0(
0.02
)0.45-0.3(
-
2.3
)0.21-3.0(
5.36
)0.005-0.3(
0.15
)0.78-0(
7.39
)0.3801-6.0(
0.81
)0.67-0(
-
SN
040.0
SN
010.0
020.0
-
35.0
)07.0-05.0(
0.53
)0.562-2.0(
0.38
)0.69-0.63(
5.41
)0.441-40.0(
0.14
)0.38-0.6(
3.31
)0.77-2.1(
45.0
)08.0-03.0(
0.42
)0.084-4.0(
0.58
)0.89-0(
0.01
)0.952-20.0(
0.53
)0.28-0(
2.11
)0.86-7.0(
SN
600.0
SN
010.0
940.0
SN
Table 2. Comparison of spermatozoa parameters in raw and inseminated semen between pregnant and non-pregnant cycles
* Values reported are the median (range)
† NS  not significant
†
dradnatS
tnanimircsid
noitcnuf
tneiciffeoc β
P
eulav
nemowfoegA
cinoirohcnamuhnolevelloidartseO
yadnihportodanog
)elpmaswar(aozotamrepslamroN
)elpmasdetanimesni(noitartnecnoC
890.0-
000.0
620.0
300.0
900.0
100.0<
110.0
930.0
Table 3. Factors of prognostic significance on multiple
logistic regression analysis
P
value
Makkar et al
344      Hong Kong Med J Vol 9 No 5 October 2003
inseminated samples demonstrated a significant correlation
with the outcome of insemination (P<0.05). The percentage
of normal forms, and the concentration of spermatozoa in
raw semen samples were other significant semen parameters
predictive of pregnancy (P<0.05).
Discussion
Controlled ovarian stimulation/IUI treatment is a less
expensive, less stressful, and less invasive treatment
compared with other assisted reproduction techniques, such
as in vitro fertilisation treatment. Consequently, it is usually
the first-line treatment offered to patients with patent
fallopian tubes and varying causes of infertility. Three
stimulated cycles have been reported as necessary to
optimise the success of IUI.8,9 Our study showed a signi-
ficantly higher PR in the first and second cycles, compared
with the third cycle. Burr et al10 have also reported a sharp
decrease in PR from the first cycle to the third cycle. A
reasonable chance of conception, however, is present even
in the third cycle. Tomlinson et al11 reported a success rate
in the third cycle of 14%, in keeping with this study’s
findings. Other studies have also reported a higher PR in
the first cycle, and that the majority of pregnancies are
established within three to four cycles. It seems then that
COS/IUI is most effective in the first three treatment cycles.
A higher number of follicles with a mean diameter of
greater than 16 mm were present in pregnant compared to
non-pregnant cycles. This was reflected in higher serum E2
level in pregnant cycles. A better PR has been reported in
cycles with three follicles of greater than 16 mm in diameter,12
as well as in cycles with two follicles of greater than 16 mm
in diameter.9 The risk of multiple pregnancy should be
taken into consideration with respect to multi-follicular
development, however.
This study found that the age of the women was a
significant discriminating factor predictive of pregnancy. No
pregnancy was achieved in women older than 38 years.
Similar reports in the literature have noted that women older
than 40 years had a poor success rate after IUI with ovarian
stimulation treatment.9,11-14 These findings are in keeping
with other previous studies documenting a decline in female
fecundity with donor spermatozoa.15-18 This decline has been
suggested to be a result of decreased oocyte quality,19,20
higher rates of chromosomal abnormalities,21 and/or reduced
uterine receptivity.22,23 Extensive counselling should be
offered to women who are older than 38 to 40 years before
they proceed to COS/IUI treatment. However, there have
been some studies showing that the success of IUI does not
decline with increasing female age.11,24
The influence of sperm parameters in predicting the
results of assisted reproductive techniques is a matter of
debate. In IUI, conventional semen parameters have been
reported to have no power to discriminate between pregnant
and non-pregnant ejaculates in either donor insemination25
or IUI programmes.13 Controversially, conventional andro-
logical diagnosis has been said to be essential for IVF or
insemination therapy.26
Sperm concentration and the number of motile sperm-
atozoa in both raw and inseminated semen samples were
significantly higher in pregnant than non-pregnant cycles
in our study. Sperm concentration, progressive motility,
and the number of motile spermatozoa have been reported
to be significantly correlated with PR in IUI,27 in donor
insemination cycles,18,28 and with the time of conception.29
Similarly, Bielsa et al30 reported that the number of motile
spermatozoa inseminated showed the best association with
fertility outcome (P<0.003). Conversely, no correlation was
demonstrated between PR and inseminated number of
motile spermatozoa by Burr et al,10 and by Horvath et al27
when the concentration of spermatozoa was between 1 and
30 million.
The chances of achieving pregnancy were reported to
be significantly increased when the raw semen sample
contained 20 million/mL or more spermatozoa, below which
the relationship between fertilisation capacity and sperm
density was said to be less predictable.31 A similar threshold
limit of approximately one million progressive motile
spermatozoa for reasonable IUI success has previously been
reported.27,32,33 However, pregnancies have been achieved
with IUI with less than one million progressive motile
spermatozoa in washed samples during natural cycles,8 with
0.8 million motile spermatozoa or more,34 and with as low
as 0.2 million motile spermatozoa.10 Notwithstanding, the
fact that the number of motile spermatozoa used for
insemination influences the outcome of IUI, highlights the
importance of using washing procedures that result in good
levels of spermatozoa recovery.3
The percentage of normal morphology in raw and insem-
inated semen samples was significantly higher in pregnant
compared with non-pregnant cycles. Moreover, the pro-
portion of normal spermatozoa in the raw semen was shown
to predict successful outcome. The percentage of normal
morphology of raw and ‘post swim-up’ semen has also been
found to correlate with in vitro fertilisation rates,30,35-37 and
with higher PRs in IUI10,38 and donor insemination pro-
grammes.39 The threshold value for normal morphology in
raw semen was 7%, below which PRs were significantly re-
duced. It has been suggested that the minimum percentage
of normal sperm in raw semen for IUI cycles should be 10%.10
Conclusion
Age of the women and E2 level had maximum power to
predict pregnancy following COS and insemination, with
lower age of women and higher E2 level correlating
positively with successful outcome. An increased number
of follicles of greater than 16 mm in diameter were present
in pregnant cycles compared with non-pregnant cycles. In
addition, sperm concentration and the number of motile
Hong Kong Med J Vol 9 No 5 October 2003      345
Prognostic factors for intrauterine insemination
spermatozoa were also significantly increased in pregnant
cycles. The PR was significantly increased when the raw
semen sample contained 20 million/mL or more
spermatozoa, normal forms comprised 7% or greater, and
when the number of motile spermatozoa in inseminated
samples was 1 million or greater.
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